Correction

Oct 4, 2004
In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.
Latest in Clinical News
Canon
Canon showcases CT innovations at RSNA 2025
December 10, 2025
Football Players Scrimmage
Adding AI to MRI improves return to play classification frameworks
December 10, 2025
Runner Street Thumbnail Adobe Augustas Cetkauskas
Marathon training does not have long-term negative effects on heart
December 10, 2025
Acquisitions
Telix and Varian enter research collaboration
December 10, 2025
Related Stories
2002 09 30 15 13 07 706
Breast
When push comes to shove: Addressing compression in mammography
2002 09 30 15 13 07 706
Breast
Preparation key to surviving MQSA inspections
2004 10 01 16 15 54 706
Clinical News
Biochem enters ultrasound domain in fetal screening
2002 09 30 15 13 07 706
Breast
Breast Imaging: The Requisites
More in Clinical News
Canon showcases CT innovations at RSNA 2025
By AuntMinnie.com staff writers
Canon exhibited two work-in-progress technologies in a research-focused section of its booth.
December 10, 2025
Canon
Adding AI to MRI improves return to play classification frameworks
By Kate Madden Yee
Predicting when athletes can safely return to play after an injury is key.
December 10, 2025
Football Players Scrimmage
Marathon training does not have long-term negative effects on heart
By Amerigo Allegretto
Echocardiography shows that endurance training by marathon runners does not have long-term negative effects on the heart.
December 10, 2025
Runner Street Thumbnail Adobe Augustas Cetkauskas
Telix and Varian enter research collaboration
By AuntMinnie.com staff writers
The two firms will identify opportunities to use Telix’s prostate cancer PET imaging agents in selecting patients for radiation therapy.
December 10, 2025
Acquisitions
Imaging Biometrics and GE HealthCare expand agreement
By AuntMinnie.com staff writers
GE HealthCare will now distribute Imaging Biometrics’ Fractional Tumor Burden (FTB) Express and QSMetric software applications.
December 10, 2025
Ai Handshake
Phase I trial reveals the potential of a new PSMA-PET tracer
By Will Morton
The radiotracer detected more lesions in men with metastatic disease than F-18 piflufolastat.
December 9, 2025
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Radiologists can designate nonmass lesions on breast ultrasound
By Amerigo Allegretto
Breast radiologists achieved moderate to substantial interreader agreement for classifying nonmass lesions on ultrasound.
December 9, 2025
Images depict a 50-year-old woman with a lesion detected during screening ultrasound. (A) Transverse and (B) longitudinal images reveal a 0.5-cm hypoechoic lesion (arrow) in the left breast. (C) Transverse color Doppler ultrasound image does not show an increase in vascularity. Two readers classified the lesion as a mass, whereas two others categorized it as a nonmass lesion, leading to its designation as a controversial nonmass lesion. Ultrasound-guided core needle biopsy and subsequent pathologic examination confirmed a nonproliferative breast change.
Long COVID's neurological effects persist
By Kate Madden Yee
Long COVID is typically defined as persistent symptoms beyond four weeks from onset of the illness.
December 9, 2025
Coronavirus
A2z raises $4.5M in seed round for CT triage system
By AuntMinnie.com staff writers
A2z Radiology has raised $4.5 million in a seed round for R&D and the commercial deployment of its abdominal/pelvic CT triage algorithm.
December 9, 2025
Computer Brain Money 400
MRI proves effective for tracking results of obesity interventions
By Kate Madden Yee
MRI is a powerful tool to monitor skeletal muscle adaptations during lifestyle interventions for obesity, researchers noted.
December 8, 2025
Obesity Text2
TVR-PET/CT shows promise in primary hyperparathyroidism
By Will Morton
Gallium-68 trivehexin PET/CT was superior for identifying lesions over technetium-99m sestamibi SPECT.
December 8, 2025
Phpt
ACR talks BI-RADS version 2025 with AuntMinnie
By Amerigo Allegretto
ACR members discussed the need to release the latest version of BI-RADS and what changes breast radiologists can expect.
December 8, 2025
Acr Logo 2023 400
Page 1 of 3708
Next Page